1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

CML - 918

Asciminib (ASC) in Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Interim Analysis (IA) Efficacy and Safety Results of the Phase 2 ASC2ESCALATE Trial in the Cohort of Newly Diagnosed Patients

Preview of Asciminib (ASC) in Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Interim Analysis (IA) Efficacy and Safety Results of the Phase 2 ASC2ESCALATE Trial in the Cohort of Newly Diagnosed Patients

View Poster Contact Presenter

Poster Presenter

Moshe Levy

Authors

Moshe Levy

Part of Topic

Chronic Myeloid Leukemia (CML)

Keywords: CML, ASC2ESCALATE, chronic myeloid leukemia, newly diagnosed, phase 2

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.